JYB1907 / Jemincare - LARVOL DELTA

Safety, efficacy, and pharmacokinetic (PK) results from a phase Ⅰ first-in-human study of JYB1907 in patients with advanced solid tumors [WITHDRAWN] (ESMO 2025) - No abstract available

Clinical • First-in-human • Metastases • P1 data • PK/PD data • Oncology • Solid Tumor

JYB1907 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=30 | Not yet recruiting | Sponsor: Jemincare | Trial primary completion date: Sep 2023 ➔ Sep 2024

Metastases • Trial primary completion date • Oncology • Solid Tumor

JYB1907 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=30 | Not yet recruiting | Sponsor: Jemincare

Metastases • New P1 trial • Oncology • Solid Tumor